NCT06777394 Effects of High Intensity Interval Training in Down Syndrome
| NCT ID | NCT06777394 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-10-27 |
| Primary Completion | 2025-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-10-27 with a primary completion date of 2025-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Down Syndrome (DS), a genetic condition marked by the presence of an extra chromosome 21, is associated with various cognitive and physical challenges. Children with DS often experience motor development issues, including reduced endurance and decreased trunk stability, which underscores the need for targeted interventions. Common impairments in individuals with DS include hypotonia, ligament laxity, reduced muscle strength, limited muscle co-contraction, poor postural control, and impaired proprioception. This study is driven by a lack of research on the effects of High-Intensity Interval Training (HIIT) in this population, despite its documented benefits in enhancing cardiovascular fitness across other groups. Existing literature supports the benefits of exercise interventions for people with DS, but the application and advantages of HIIT-particularly concerning endurance and trunk stability-are underexplored.
Eligibility Criteria
Inclusion Criteria: * Age group between 3 to 14 years * clinically diagnose in children with down syndrome Exclusion criteria * Any neurological condition * History of dementia
Contact & Investigator
Sheza Khan, MS*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06777394 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 14 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06777394 currently recruiting?
Yes, NCT06777394 is actively recruiting participants. Contact the research team at imranamjad@riphah.edu.pk for enrollment information.
Where is the NCT06777394 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06777394 clinical trial?
NCT06777394 is sponsored by Riphah International University. The principal investigator is Sheza Khan, MS* at Riphah International University. The trial plans to enroll 30 participants.